Table 1.
| Category | GenBank accession no. | Gene name or product | Fold change in BMMϕ versus BMMϕ plus IFN-γ | Fold change in MEF versus MEF plus IFN-γ |
|---|---|---|---|---|
| a: Specifically | AA163727 | ZW1- homolog (Drosophila), centromere/kinetochore protein | −5.9 | −1.2 |
| down in BMMϕ | AA276440 | Selenoprotein P, plasma, 1 | −5.8 | 1.3 |
| W59165 | Folate binding protein 2 | −5.8 | −1.1 | |
| AA138966 | EST | −5.2 | 1.1 | |
| b: Specifically | AA058055 | EST | −1.4 | −5 |
| down in MEF | AA030821 | EST | −1.2 | −5 |
| AA008052 | EST | −1.2 | −5.2 | |
| W14275 | EST | 1 | −6.1 | |
| W85641 | EST | 1.1 | −5.3 | |
| AA175695 | EST | 1.1 | −6.2 | |
| W63822 | Homeo box A2 | 1.1 | −6.4 | |
| W14332 | EST | 1.2 | −5.2 | |
| AA390032 | EST | 1.2 | −5.8 | |
| W97155 | EST | 1.2 | −6.1 | |
| AA216849 | EST | 1.3 | −5.9 | |
| AA538511 | Histocompatibility 2, D region locus 1 | 2.8 | −7.6 | |
| AA240404 | Putative purine nucleotide binding protein mRNA | 2.9 | −8.9 | |
| c: Specifically | AA245029 | EST | −1.1 | 6 |
| up in MEF | AA209006 | EST | 1 | 6.7 |
| d: Specifically | AA217290 | EST | 5.3 | 1.6 |
| up in BMMϕ | AA177481 | EST | 5.5 | −1.3 |
| AA458171 | EST | 5.6 | 1.6 | |
| AA230649 | Histocompatibility 2, class II, locus DMa | 5.9 | 1.9 | |
| AA269724, AA277329 | H-2 class II histocompatibility antigen, I-A β chain precursor | 7.3 | 1.5 | |
| AA462202 | BP-3 alloantigen | 9.1 | 1.5 | |
| W34612 | Transglutaminase 2, C polypeptide | 10 | 1.1 | |
| e: Upregulated | AA186012 | Histocompatibility 2, Q region locus 7 | 3 | 5.6 |
| in BMMϕ | AA177731 | EST | 3.3 | 5.2 |
| and MEF | AA143986 | EST | 3.8 | 5.9 |
| AA109951 | β2 microglobulin | 4.5 | 9.1 | |
| AA140542 | EST | 4.7 | 14.2 | |
| AA138757 | EST | 5.4 | 13.2 | |
| AA451385 | EST | 5.4 | 3.7 | |
| AA174721 | EST | 5.5 | 11 | |
| AA286393, AA172456 | Small inducible cytokine A12 | 5.9 | 4.2 | |
| AA123837 | Transporter 1, ABC (ATP binding cassette) | 6.2 | 3.1 | |
| AA388678 | STAT 1 | 6.4 | 5.1 | |
| AA475774 | Cathepsin C | 6.6 | 3.2 | |
| AA272807 | Histocompatibility 2, class II antigen A, alpha | 7.5 | 4.6 | |
| AA172624 | EST | 8.9 | 14.1 | |
| AA145136 | EST | 8.9 | 16.1 | |
| AA260490 | EST | 9.1 | 8.3 | |
| AA204588 | EST | 9.5 | 15.4 | |
| AA122443 | EST | 11 | 11.6 | |
| AA472492 | Monokine induced by IFN-γ | 14.9 | 12.5 | |
| AA153021, AA277451 | IFN-induced guanylate binding protein | 19.8 | 21.3 | |
| W83447, AA210495 | Spi2 proteinase inhibitor (spi2/eb1) | 30.1 | 7.8 | |
| AA000712, AA472994AA145865 | Lymphocyte antigen 6 complex | 46.2 | 12.5 |
GenBank accession numbers, gene names, and fold changes in gene expression are listed from top to bottom in the same order as left to right in Fig. 5C and Fig. D, for all genes changed more than fivefold in either MEFs or BMMϕ by IFN-γ treatment. The lower case letters in the left column correspond to those in Fig. 5C and Fig. D.